These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 15297044)
1. Systematic review of the effects of pertussis vaccines in children. Simondon F Vaccine; 2004 Aug; 22(23-24):2965. PubMed ID: 15297044 [No Abstract] [Full Text] [Related]
8. Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components. Zieliński A; Rosińska M Przegl Epidemiol; 2008; 62(3):589-96. PubMed ID: 19108523 [TBL] [Abstract][Full Text] [Related]
9. Acellular pertussis vaccines in Japan: past, present and future. Watanabe M; Nagai M Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991 [TBL] [Abstract][Full Text] [Related]
10. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. Hallander HO; Ljungman M; Storsaeter J; Gustafsson L APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children. Lacombe K; Yam A; Simondon K; Pinchinat S; Simondon F Vaccine; 2004 Dec; 23(5):623-8. PubMed ID: 15542182 [TBL] [Abstract][Full Text] [Related]
12. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy. Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604 [TBL] [Abstract][Full Text] [Related]
13. Acellular pertussis vaccines in China. Wang L; Lei D; Zhang S Vaccine; 2012 Nov; 30(50):7174-8. PubMed ID: 23084855 [TBL] [Abstract][Full Text] [Related]
14. Improved protocols for histamine sensitization testing of acellular pertussis vaccines. Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771 [TBL] [Abstract][Full Text] [Related]
15. Shortcomings of pertussis vaccines: why we need a third generation vaccine. Poolman JT Expert Rev Vaccines; 2014 Oct; 13(10):1159-62. PubMed ID: 25089373 [TBL] [Abstract][Full Text] [Related]
16. Has the change to acellular pertussis vaccine improved or worsened pertussis control? Halperin SA; De Serres G CMAJ; 2006 Nov; 175(10):1227. PubMed ID: 17098952 [No Abstract] [Full Text] [Related]
17. Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands. Keijzer-Veen MG; Holty-van der Wekken L; Juttmann RE; de Groot R; Rümke HC Vaccine; 2004 Sep; 22(25-26):3256-7. PubMed ID: 15308347 [TBL] [Abstract][Full Text] [Related]
18. [Prevention of pertussis and high expectations concerning vaccines]. Wysocki J Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156 [TBL] [Abstract][Full Text] [Related]
19. Possible options for new pertussis vaccines. Meade BD; Plotkin SA; Locht C J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868 [TBL] [Abstract][Full Text] [Related]
20. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines. Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]